Delivery Order SPE2DB20D3303-SPE2DB26FY2M0
Award Date 11/7/25
Potential Completion Date 11/10/25
Potential Value $1.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $7,446.61 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day transdermal patches (3-count packages) on November 4, 2025, with an ultimate completion date of November 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single-transaction delivery under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Xulane 150-35 mcg/day transdermal patches (3-count units) valued at $7,555.01. This competitively awarded, firm fixed-price delivery order is set to complete by August 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement under the company's existing federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for $4,418.88 to supply Xulane 150-35 mcg/day transdermal patches (quantity: 3 units). This is a firm fixed price delivery order with no set-aside designation, completed competitively under the company's larger indefinite delivery contract with DLA Troop Support Medical. The order is set to be fulfilled by the ultimate completion date of August 13, 2025, with the place of performance in...
- The Defense Logistics Agency awarded a delivery order valued at $1,983.30 to AmerisourceBergen Drug Corp for XULANE 150-35 mcg/day transdermal patches (3-count units) on August 20, 2025, with completion expected by August 21, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location...
- The Defense Logistics Agency awarded a $2,138.43 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day transdermal patches (3 patches) on July 14, 2025, with an ultimate completion date of July 15, 2025. This competitive award, with no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as...
- The Defense Logistics Agency awarded a delivery order valued at $4,098.09 to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Xulane 150-35 mcg/day transdermal patches (3-count). This is a firm fixed-price delivery order with an ultimate completion date of October 24, 2025, issued under a non-set-aside competitive procurement. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at approximately $23.8k to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day transdermal patches (3-count units). This firm fixed-price, competitively awarded delivery order was issued on August 14, 2025, with an ultimate completion date of August 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract contains no set-aside designation. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,610.48 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day transdermal patches (3-unit supply) on June 20, 2025, with an ultimate completion date of June 23, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a $3,077.49 delivery order to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day transdermal patches (3-count) on October 29, 2025, with completion scheduled for October 30, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen,...
- The Defense Logistics Agency awarded a delivery order valued at $1,320.39 to AmerisourceBergen Drug Corp for XULANE 150-35 mcg/day transdermal patches (3-count units) on August 19, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...